CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −156 | $280.71 | $44K | 7,125 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −522 | $281.64 | $147K | 6,603 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −653 | $282.13 | $184K | 5,950 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −955 | $283.43 | $271K | 4,995 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −1,204 | $284.25 | $342K | 3,791 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −59 | $285.30 | $17K | 3,732 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −148 | $286.26 | $42K | 3,584 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −147 | $287.41 | $42K | 3,437 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −9 | $288.80 | $3K | 3,428 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −125 | $289.89 | $36K | 3,303 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −413 | $291.57 | $120K | 2,890 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −13 | $294.05 | $4K | 2,877 |
| 2021-02-16 | Glenn Gregory M President, R&D | Sale | −66 | $296.58 | $20K | 2,811 |
| 2021-02-16 | Glenn Gregory M President, R&D | Exercise or conversion | +4,819 | $5.95 | $29K | 7,630 |
| 2021-02-16 | Glenn Gregory M President, R&D | Returned to the company | −110 | $262.70 | $29K | 7,520 |
| 2021-02-16 | Glenn Gregory M President, R&D | Shares withheld for taxes | −2,275 | $262.70 | $598K | 5,245 |
| 2021-02-16 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −619 | 2,480 | ||
| 2021-02-16 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −868 | 7,473 | ||
| 2021-02-16 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −1,101 | 17,423 | ||
| 2021-02-16 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −3,124 | 71,876 |
Page 70 of 87 · 1,734 trades